Comparison of the Efficacy and Safety of Icotinib with Standard Second-line 
Chemotherapy in Previously Treated Advanced Non-small Cell Lung Cancer

Comparison of the Efficacy and Safety of Icotinib with Standard Second-line 
Chemotherapy in Previously Treated Advanced Non-small Cell Lung Cancer

Background and objective This study compared the efficacy and safety of icotinib with standard second-line chemotherapy (single-agent docetaxel or pemetrexed) in previously treated advanced non-small cell lung cancer (NSCLC). Methods Thirty-two consecutive patients treated with icotinib and 33 conse...

Full description

Bibliographic Details
Main Authors: Shuyang YAO, Kun QIAN, Ruotian WANG, Yuanbo LI, Yi ZHANG
Format: Article
Language:zho
Published: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2015-06-01
Series:Chinese Journal of Lung Cancer
Subjects:
Lung neoplasms
Icotinib
Chemotherapy
Online Access:http://dx.doi.org/10.3779/j.issn.1009-3419.2015.06.07

Internet

http://dx.doi.org/10.3779/j.issn.1009-3419.2015.06.07

Similar Items